Barclays PLC boosted its holdings in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 106.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 68,646 shares of the electronics maker's stock after purchasing an additional 35,416 shares during the quarter. Barclays PLC owned about 0.07% of Dolby Laboratories worth $5,359,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of DLB. Savant Capital LLC grew its holdings in shares of Dolby Laboratories by 2.0% during the fourth quarter. Savant Capital LLC now owns 6,274 shares of the electronics maker's stock valued at $490,000 after buying an additional 125 shares during the last quarter. Orion Portfolio Solutions LLC increased its holdings in Dolby Laboratories by 0.7% during the 4th quarter. Orion Portfolio Solutions LLC now owns 19,522 shares of the electronics maker's stock worth $1,525,000 after purchasing an additional 132 shares in the last quarter. Harbor Capital Advisors Inc. increased its holdings in Dolby Laboratories by 5.6% during the 4th quarter. Harbor Capital Advisors Inc. now owns 2,571 shares of the electronics maker's stock worth $201,000 after purchasing an additional 136 shares in the last quarter. Mather Group LLC. lifted its holdings in shares of Dolby Laboratories by 36.8% in the fourth quarter. Mather Group LLC. now owns 528 shares of the electronics maker's stock valued at $41,000 after purchasing an additional 142 shares in the last quarter. Finally, Naples Global Advisors LLC boosted its position in shares of Dolby Laboratories by 0.4% during the fourth quarter. Naples Global Advisors LLC now owns 35,730 shares of the electronics maker's stock valued at $2,791,000 after buying an additional 160 shares during the last quarter. Institutional investors and hedge funds own 58.56% of the company's stock.
Analyst Ratings Changes
A number of research analysts have issued reports on the company. Rosenblatt Securities restated a "buy" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research note on Thursday, January 30th. StockNews.com downgraded shares of Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a report on Friday, January 31st. Finally, Barrington Research reissued an "outperform" rating and set a $100.00 target price on shares of Dolby Laboratories in a research report on Thursday, February 13th.
View Our Latest Research Report on Dolby Laboratories
Dolby Laboratories Stock Performance
DLB stock traded down $0.12 during midday trading on Wednesday, reaching $76.28. 155,540 shares of the company's stock traded hands, compared to its average volume of 452,388. Dolby Laboratories, Inc. has a 52 week low of $66.35 and a 52 week high of $89.66. The company has a 50-day moving average price of $78.06 and a two-hundred day moving average price of $78.30. The firm has a market capitalization of $7.28 billion, a PE ratio of 28.04 and a beta of 0.94.
Insider Buying and Selling
In other news, CMO Todd Pendleton sold 18,121 shares of the company's stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $83.75, for a total value of $1,517,633.75. Following the transaction, the chief marketing officer now owns 37,290 shares of the company's stock, valued at approximately $3,123,037.50. This represents a 32.70 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Ryan Nicholson sold 7,000 shares of Dolby Laboratories stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $84.07, for a total value of $588,490.00. Following the sale, the chief accounting officer now directly owns 29,758 shares of the company's stock, valued at $2,501,755.06. This represents a 19.04 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 65,121 shares of company stock valued at $5,501,324. Corporate insiders own 38.39% of the company's stock.
Dolby Laboratories Profile
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Read More

Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.